APA aipamena

Fiorillo, M., Sotgia, F., Sisci, D., Cappello, A. R., & Lisanti, M. P. (2017). Mitochondrial “power” drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer. Oncotarget.

Chicago Style aipamena

Fiorillo, Marco, Federica Sotgia, Diego Sisci, Anna Rita Cappello, and Michael P. Lisanti. "Mitochondrial “power” Drives Tamoxifen Resistance: NQO1 and GCLC Are New Therapeutic Targets in Breast Cancer." Oncotarget 2017.

MLA aipamena

Fiorillo, Marco, et al. "Mitochondrial “power” Drives Tamoxifen Resistance: NQO1 and GCLC Are New Therapeutic Targets in Breast Cancer." Oncotarget 2017.